Topical NVN1000 for the Treatment of External Genital and Perianal Warts

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

June 12, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 17, 2016

Conditions
Genital WartsPerianal Warts
Interventions
DRUG

NVN1000 8% Gel

once and twice daily

DRUG

NVN1000 16%

once daily

DRUG

Vehicle

placebo comparator

DRUG

NVN1000 24%

once daily

Trial Locations (15)

19107

PPD 135, Philadelphia

30005

PPD 134, Atlanta

30075

PPD 138, Roswell

30338

PPD 139, Atlanta

46202

PPD 130, Indianapolis

70006

PPD 126, Metairie

75598

PPD 131, Webster

77023

PPD 129, Houston

78229

PPD 127, San Antonio

78414

PPD 128, Corpus Christi

90717

PPD 140, Lomita

92123

PPD 133, San Diego

92708

PPD 137, Fountain Valley

97210

PPD 132, Portland

98105

PPD 136, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

PPD Development, LP

INDUSTRY

lead

Novan, Inc.

INDUSTRY